GGCX
Vitamin K-dependent gamma-carboxylase
Also known as: VKCFD1, VKGC_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P38435
- Gene
- GGCX
- Ensembl
- ENSG00000115486
- Chromosome
- 2
- Canonical length
- 758 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes an integral membrane protein of the rough endoplasmic reticulum that carboxylates glutamate residues of vitamin K-dependent proteins to gamma carboxyl glutamate, a modification that is required for their activity. The vitamin K-dependent protein substrates have a propeptide that binds the enzyme, with carbon dioxide, dioxide, and reduced vitamin K acting as co-substrates. Vitamin K-dependent proteins affect a number of physiologic processes including blood coagulation, prevention of vascular calcification, and inflammation. Allelic variants of this gene have been associated with pseudoxanthoma elasticum-like disorder with associated multiple coagulation factor deficiency. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
Canonical amino-acid sequenceUniProt
758 residues, UniProt reviewed canonical sequence.
>P38435|GGCX
1 MAVSAGSART SPSSDKVQKD KAELISGPRQ DSRIGKLLGF EWTDLSSWRR LVTLLNRPTD
61 PASLAVFRFL FGFLMVLDIP QERGLSSLDR KYLDGLDVCR FPLLDALRPL PLDWMYLVYT
121 IMFLGALGMM LGLCYRISCV LFLLPYWYVF LLDKTSWNNH SYLYGLLAFQ LTFMDANHYW
181 SVDGLLNAHR RNAHVPLWNY AVLRGQIFIV YFIAGVKKLD ADWVEGYSME YLSRHWLFSP
241 FKLLLSEELT SLLVVHWGGL LLDLSAGFLL FFDVSRSIGL FFVSYFHCMN SQLFSIGMFS
301 YVMLASSPLF CSPEWPRKLV SYCPRRLQQL LPLKAAPQPS VSCVYKRSRG KSGQKPGLRH
361 QLGAAFTLLY LLEQLFLPYS HFLTQGYNNW TNGLYGYSWD MMVHSRSHQH VKITYRDGRT
421 GELGYLNPGV FTQSRRWKDH ADMLKQYATC LSRLLPKYNV TEPQIYFDIW VSINDRFQQR
481 IFDPRVDIVQ AAWSPFQRTS WVQPLLMDLS PWRAKLQEIK SSLDNHTEVV FIADFPGLHL
541 ENFVSEDLGN TSIQLLQGEV TVELVAEQKN QTLREGEKMQ LPAGEYHKVY TTSPSPSCYM
601 YVYVNTTELA LEQDLAYLQE LKEKVENGSE TGPLPPELQP LLEGEVKGGP EPTPLVQTFL
661 RRQQRLQEIE RRRNTPFHER FFRFLLRKLY VFRRSFLMTC ISLRNLILGR PSLEQLAQEV
721 TYANLRPFEA VGELNPSNTD SSHSNPPESN PDPVHSEFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GGCX can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 9
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 101 nTPM
Expression across tissuesHPA
Tissue
- liver: 101 nTPM
- epididymis: 25 nTPM
- placenta: 23 nTPM
- parathyroid gland: 20 nTPM
- tongue: 20 nTPM
- choroid plexus: 18 nTPM
Single-cell type
- epicardial cells: 491 nCPM
- cardiomyocytes: 194 nCPM
- hepatocytes: 181 nCPM
- epididymal principal cells: 110 nCPM
- cytotrophoblasts: 75 nCPM
- extravillous trophoblasts: 65 nCPM
Immune cell
- plasmacytoid DC: 35 nTPM
- intermediate monocyte: 24 nTPM
- classical monocyte: 22 nTPM
- myeloid DC: 22 nTPM
- eosinophil: 22 nTPM
- neutrophil: 21 nTPM
Brain region
- choroid plexus: 27 nTPM
- white matter: 23 nTPM
- thalamus: 17 nTPM
- cerebral cortex: 16 nTPM
- cerebellum: 16 nTPM
- spinal cord: 16 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GGCX.
Disease | AllUniProt
Conditions GGCX is implicated in, by any mechanism.
- Combined deficiency of vitamin K-dependent clotting factors 1 (VKCFD1) MIM:277450
- Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency (PXEL-MCFD) MIM:610842
Disease | GeneticClinVar
54 pathogenic / likely-pathogenic of 615 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Vitamin K-dependent clotting factors, combined deficiency of, type 1
- Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency
- GGCX-related disorder
- Hepatocellular carcinoma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.88
- DepMap mean gene effect
- -0.21
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blood coagulation
- cellular response to insulin stimulus
- glucose homeostasis
- negative regulation of bone development
- negative regulation of neurotransmitter secretion
- negative regulation of testosterone biosynthetic process
- protein maturation
- protein modification process
- type B pancreatic cell proliferation
- vitamin K metabolic process
Molecular functions
- vitamin binding
- gamma-glutamyl carboxylase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RmlC-like cupin domain superfamily
- RmlC-like jelly roll fold
- Vitamin K-dependent gamma-carboxylase
- HTTM-like
- HTTM domain
- Vitamin K-dependent gamma-carboxylase, lumenal domain
- HTTM domain
- Vitamin K-dependent gamma-carboxylase, lumenal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GGCX in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GGCX as an antibody target. Whether an autoantibody or antibody against GGCX could matter depends on whether native GGCX is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GGCX is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GGCX as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...